Market Snapshot
S&P Futures
4,281.5
Dow Futures
33,883
Nasdaq Futures
13,553.5
Vascular Biogenics Ltd. (VBLT) stock rallied over 2.85% intraday to trade at $0.2417 a share on NASDAQ. The stock opened with a loss of -2.15% at $0.235 and touched an intraday high of $0.242, rising 4.18% against the last close of $0.232. The stock went to a low of $0.225 during the session.
Prev. Close
Market Cap
Day Low
Open
Number of Shares
Day High
P/E ratio
EPS (TTM)
Cash Flow per Share
Free Float in %
Book Value
Volume
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
2022-08-17 | $0.235 | $0.242 | $0.225 | $0.235 | 4,636,280 |
2022-08-16 | $0.247 | $0.247 | $0.23 | $0.232 | 2,900,700 |
2022-08-15 | $0.23 | $0.248 | $0.23 | $0.241 | 3,994,900 |
2022-08-12 | $0.25 | $0.255 | $0.23 | $0.24 | 3,574,500 |
2022-08-11 | $0.26 | $0.273 | $0.245 | $0.25 | 4,352,700 |
2022-08-10 | $0.241 | $0.26 | $0.24 | $0.258 | 4,970,500 |
2022-08-09 | $0.247 | $0.274 | $0.24 | $0.241 | 8,605,900 |
2022-08-08 | $0.23 | $0.26 | $0.23 | $0.252 | 8,491,500 |
2022-08-05 | $0.24 | $0.245 | $0.231 | $0.237 | 3,620,700 |
2022-08-04 | $0.236 | $0.258 | $0.236 | $0.243 | 5,531,500 |
Employees-
Beta0.59
Sales or Revenue696 Thousands
5Y Sales Change-
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryBiotechnology
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antibody-based technology that enables specifically inhibit monocyte migration for immune-inflammatory applications. The company's lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the recurrent platinum-resistant ovarian cancer; and Phase II clinical trials treatment of recurrent glioblastoma and colorectal cancer, as well as has completed Phase II clinical trial for the treatment of thyroid cancer. It is also developing VB-601 for various inflammatory indications, and VB-611 for various solid tumors. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.
Vascular Biogenics Ltd. (NASDAQ: VBLT) stock price is $0.2417 as of the last check on Wednesday, August 17. During the trading session, VBLT stock reached the peak price of $0.242 while $0.225 was the lowest point it dropped to.
The NASDAQ listed VBLT is part of Biotechnology industry that operates in the broader Health Care sector. Vascular Biogenics Ltd. , a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States.
Dr. Erez Feige M.B.A., Ph.D.
VP of Bus. Operations
Dr. Eyal Breitbart Ph.D.
VP of Research & Operations
Dr. Naamit Sher Ph.D.
VP of Drug Devel. & Regulatory Affairs
Dr. Yael Cohen
Medical Director
VBLT stock traded closed the last session at $0.235, which is $0.0067000000000000115 or 2.8510638297872393% lower than its previous close of $0.232. VBLT's current trading price is 11.85% lower than its 52-week high of $2.54 where as its distance from 52-week low of 0.21% is -90.75%.
Number of VBLT employees currently stands at -. VBLT operates from 8 HaSatat Street, Hevel Modi'in 7178106, Israel.
Official Webiste of $VBLT is: https://www.vblrx.com
VBLT could be contacted at VBLT operates from 8 HaSatat Street, Hevel Modi'in 7178106, Israel, or at phone #972 8 993 5000 and can also be accessed through its website.
VBLT stock volume for the day was 3,048,147 shares while in the previous session number of VBLT shares traded was 4,636,280 . The average number of VBLT shares traded daily for last 3 months was 3 Million.
The percentage change in VBLT stock occurred in the recent session was 2.8510638297872393% while the dollar amount for the price change in VBLT stock was $0.0067000000000000115.
In the recent session, the day high for VBLT stock was $0.242 while the low for VBLT stock touched on the day was $0.225.
The market value of VBLT currently stands at 17.04 Million with its latest stock price at $0.2417 and 77.39 Million of its shares outstanding.